Omnicell Inc. (OMCL)
NASDAQ: OMCLTechnologyComputer ManufacturingUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
OMCL stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.50B
- P/E (TTM)
- 33.86
- Forward P/E
- 16.18
- EPS (TTM)
- $0.96
- Dividend yield
- None
- 52-week range
- 31.75 – 55.00
- Day range
- 32.27 – 33.39
- Volume / Avg
- 564.52K / 559.37K
- Beta
- —
- Shares outstanding
- 46.00M
52-week range
OMCL stock today
Omnicell (OMCL) closed at $32.51 on Nov 20, down 2.02% (-$0.67), versus the S&P 500's 3.70% decline. Shares are 40.9% below their 52-week high of $55.00, set on Jan 13, 2026 and 2.4% above the 52-week low of $31.75, near the bottom of the past year's range. OMCL is down 28.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 9.7%.
At 33.9x trailing earnings, Omnicell trades above the peer-group median of 16.2x. Its forward P/E of 16.2x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Omnicell
Company profileOmnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services.
- Sector
- Technology
- Industry
- Computer Manufacturing
- CEO
- Mr. Randall A. Lipps
- Headquarters
- Fort Worth, TX
- Employees
- 3,450
- IPO year
- 2001
- Website
- omnicell.com
Financial highlights
Full financialsIn fiscal 2025, Omnicell generated $1.18 billion in revenue, up 6.5% from fiscal 2024. Net income was $2.1 million (-83.6% year over year), for a net margin of 0.2% versus a median of 1.1% in the prior 5 years. Gross margin was 42.5% (up from 42.3%) and operating margin 0.4%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $1.18B | $1.11B | $1.15B | $1.30B | $1.13B |
| Growth | +6.53% | -3.04% | -11.48% | +14.48% | +26.88% |
| Net income | $2.05M | $12.53M | $-20.37M | $5.65M | $77.85M |
| EPS (diluted) | $0.04 | $0.27 | $-0.45 | $0.12 | $1.62 |
Analyst forecast
ForecastConsensus (8 analysts)
none
Avg. price target
$57.43+76.65%
- Strong buy 1
- Buy 6
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Oct 29, 2026
- EPS actual vs est.
- $0.32 vs $0.24
- Surprise
- +33.33%
OMCL news
All OMCL news- Is This the Right Time to Retain Omnicell Stock in Your Portfolio?NasdaqOMCL, IDXX, PODD, BLCO
- Beat Value Traps: 4 Stocks With Attractive PEG Ratios to Buy NowNasdaqAVT, SNDK, OMCL, MPC
- Zacks.com featured highlights include Cinemark, Diamondback Energy and OmnicellNasdaqOMCL, CNK, FANG
- Zacks.com featured highlights include Avnet, Omnicell, Hewlett Packard and Lifetime BrandsNasdaqAVT, OMCL, HPE, LCUT
- Buy These 3 Stocks with Broker Rating Upgrades for Big GainsNasdaqOMCL, CNK, FANG
- 4 Undervalued Stocks That Could Benefit from a Wall Street RallyNasdaqAVT, OMCL, HPE, LCUT
- OMCL vs. VEEV: Which Stock Should Value Investors Buy Now?NasdaqOMCL, VEEV
- Top Robotics Stocks With Strong Potential for Long-Term GrowthNasdaqOMCL, MCHP, SNPS, CDNS
Omnicell peers
Technology sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| XNDUXanadu Quantum Technologies Limited Class B Subordinate Voting Shares | 1.70 | -6.59% | $536.15M | vs OMCL |
| OSSOne Stop Systems Inc. | 4.01 | -7.82% | $100.40M | vs OMCL |
| ZEPPZepp Health Corporation ADR | 2.31 | -8.33% | $33.88M | vs OMCL |
| SMCISuper Micro Computer Inc. | 21.65 | -9.19% | $14.27B | vs OMCL |
| HPQHP Inc. | 27.96 | +0.50% | $25.21B | vs OMCL |
| DELLDell Technologies Inc. Class C | 278.02 | -11.04% | $176.77B | vs OMCL |
| IBMInternational Business Machines Corporation | 224.44 | +0.25% | $212.12B | vs OMCL |
| AAPLApple Inc. | 342.56 | -1.90% | $4.98T | vs OMCL |
Indexes, lists and sector
Appears in lists
Largest Technology stocks
Omnicell stock FAQ
What is Omnicell's stock price today?
OMCL last traded at $32.51 as of Nov 20, 4:00 PM EST, down 2.02% on the day. Prices are delayed at least 15 minutes.
What is OMCL's P/E ratio?
OMCL trades at a trailing P/E ratio of 33.86 and a forward P/E of 16.18, compared with a median of 16.2 for its closest peers.
Who is Omnicell's CEO?
Mr. Randall A. Lipps is the chief executive officer of Omnicell Inc., which has about 3,450 employees.
What is the OMCL 52-week high?
The 52-week high for OMCL is $55.00 and the 52-week low is $31.75. The stock is currently 40.9% below its high.